The Company's test for Lassa hemorrhagic fever disease is now CE marked and in testing in several African countries.

The Company's ReEBOV test for Ebola hemorrhagic fever disase has now been approved under emergency use regulatiuons by the World Health Organization (WHO) and the U.S. Food and Drug Administration (FDA).

Click on Lassa Fever or Ebola Fever for more information about Autoimmune's work in these extermely important areas.